Skip to main navigation Skip to search Skip to main content

Gabapentin hybrid peptides and bioconjugates

  • Iryna Oleksandrivna Lebedyeva
  • , David A. Ostrov
  • , John Neubert
  • , Peter J. Steel
  • , Kunal Patel
  • , Sean M. Sileno
  • , Kevin Goncalves
  • , Mohamed A. Ibrahim
  • , Khalid A. Alamry
  • , Alan R. Katritzky

Research output: Contribution to journalArticlepeer-review

Abstract

Synthetic approaches to gabapentin bioconjugates that overcome the tendency of gabapentin to cyclize into its γ-lactam are studied. Gabapentin was converted by N-acylation at its N-terminus into di-, tri-, and tetrapeptides (L-Ala-Gbp, L-Val-Gbp, L-Ala-L-Phe-Gbp, Gly-L-Ala-β-Ala-Gbp). Carboxyl-activated Boc-protected gabapentin was used to N-, O-, and S-acylate small peptides and hormones to give conjugates that could also provide prodrugs containing conformationally constrained gabapentin units.

Original languageEnglish (US)
Pages (from-to)1479-1486
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume22
Issue number4
DOIs
StatePublished - Feb 15 2014
Externally publishedYes

Keywords

  • Benzotriazole
  • Coupling
  • Cyclization
  • Gabapentin
  • Peptide

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Gabapentin hybrid peptides and bioconjugates'. Together they form a unique fingerprint.

Cite this